Your search returned 10 results.

Results
	1.	[Application of lateral cervical incision in the removal of the cervical esophageal foreign body]. [electronic resource] by Yu, De-zhi Qiu, Jing-xin Liu, Ye-hai Yang, Ke-lin Tao, Ye Producer: 20110203 In: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery vol. 45 Availability: No items available. Save to lists Add to cart (remove)
	2.	MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis. [electronic resource] by Tu, Mei-Juan Pan, Yu-Zhuo Qiu, Jing-Xin Kim, Edward J Yu, Ai-Ming Producer: 20180130 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest. [electronic resource] by Zhao, Yong Tu, Mei-Juan Wang, Wei-Peng Qiu, Jing-Xin Yu, Ai-Xi Yu, Ai-Ming Producer: 20180329 In: Scientific reports vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity. [electronic resource] by Jilek, Joseph L Zhang, Qian-Yu Tu, Mei-Juan Ho, Pui Yan Duan, Zhijian Qiu, Jing-Xin Yu, Ai-Ming Publication details: Molecular therapy. Nucleic acids Mar 2019 In: Molecular therapy. Nucleic acids vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth. [electronic resource] by Zhao, Yong Tu, Mei-Juan Yu, Yi-Feng Wang, Wei-Peng Chen, Qiu-Xia Qiu, Jing-Xin Yu, Ai-Xi Yu, Ai-Ming Producer: 20160314 In: Biochemical pharmacology vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis. [electronic resource] by Bi, Hui-Chang Pan, Yu-Zhuo Qiu, Jing-Xin Krausz, Kristopher W Li, Fei Johnson, Caroline H Jiang, Chang-Tao Gonzalez, Frank J Yu, Ai-Ming Producer: 20150511 In: Carcinogenesis vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models. [electronic resource] by Tu, Mei-Juan Ho, Pui Yan Zhang, Qian-Yu Jian, Chao Qiu, Jing-Xin Kim, Edward J Bold, Richard J Gonzalez, Frank J Bi, Huichang Yu, Ai-Ming Producer: 20191104 In: Cancer letters vol. 442 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models. [electronic resource] by Jian, Chao Tu, Mei-Juan Ho, Pui Yan Duan, Zhijian Zhang, Qianyu Qiu, Jing-Xin DeVere White, Ralph W Wun, Theodore Lara, Primo N Lam, Kit S Yu, Ai-Xi Yu, Ai-Ming Producer: 20180305 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy. [electronic resource] by Ho, Pui Yan Duan, Zhijian Batra, Neelu Jilek, Joseph L Tu, Mei-Juan Qiu, Jing-Xin Hu, Zihua Wun, Theodore Lara, Primo N DeVere White, Ralph W Chen, Hong-Wu Yu, Ai-Ming Producer: 20191014 In: The Journal of pharmacology and experimental therapeutics vol. 365 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization. [electronic resource] by Wang, Wei-Peng Ho, Pui Yan Chen, Qiu-Xia Addepalli, Balasubrahmanyam Limbach, Patrick A Li, Mei-Mei Wu, Wen-Juan Jilek, Joseph L Qiu, Jing-Xin Zhang, Hong-Jian Li, Tianhong Wun, Theodore White, Ralph DeVere Lam, Kit S Yu, Ai-Ming Producer: 20150915 In: The Journal of pharmacology and experimental therapeutics vol. 354 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)